Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario
University of Toronto · Public Health Ontario · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
260
total citations
- FWCI
- 25.40
- Percentile
- 100%
- References
- 17
Citations per year
Authors
16- SNSharifa NasreenCorresponding
University of Toronto, Public Health Ontario, Institute for Clinical Evaluative Sciences
- HCHannah Chung
Institute for Clinical Evaluative Sciences
- SHSiyi He
Institute for Clinical Evaluative Sciences
- KAKevin A. Brown
University of Toronto, Public Health Ontario, Institute for Clinical Evaluative Sciences
- JBJonathan B. Gubbay
Public Health Ontario
Topics & keywords
Topics
Keywords
- Medicine
- Coronavirus disease 2019 (COVID-19)
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Population
- Internal medicine
- Disease
- Pediatrics
- Immunology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- CCCancer Care Ontario
- PHPublic Health Agency of CanadaAwards: CNF 151944, 151944
- PHPublic Health Agency
- UOUniversity of Toronto
- CICanadian Immunization Research NetworkAward: CNF 151944
- CICanadian Institutes of Health ResearchAwards: 151944, COVID-19, CNF 151944
- DODepartment of Family and Community Medicine, University of Toronto